Aspirin Resistance in OSA Patients

Completed

Conditions studied: Obstructive Sleep Apnea

In brief

Obstructive Sleep Apnea (OSA) patients are at increased risk of major cardiovascular events, so many patients take aspirin for prevention. Poor responsiveness to aspirin is a major clinical concern because it can potentially worsen the prognosis of OSA patients. However, continuous positive airway pressure (CPAP) therapy that is considered standard of care for OSA treatment may potentially lead to improvement in responsiveness to aspirin. This study will determine whether CPAP therapy decreases patients' aspirin resistance in OSA patients with a new diagnosis or existing moderate to severe OSA who are treated with CPAP and take aspirin for prevention.

Key facts

Study ID
NCT03930875
Run by
Danbury Hospital
People needed
63
Starts
2017-12-12
Expected to finish
2018-09-07
Last updated by the study team
2019-04-29

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.